| Product NDC: | 66758-044 |
| Proprietary Name: | Fluorouracil |
| Non Proprietary Name: | Fluorouracil |
| Active Ingredient(s): | 50 mg/mL & nbsp; Fluorouracil |
| Administration Route(s): | INTRAVENOUS |
| Dosage Form(s): | INJECTION, SOLUTION |
| Coding System: | National Drug Codes(NDC) |
| Product NDC: | 66758-044 |
| Labeler Name: | Sandoz Inc |
| Product Type: | HUMAN PRESCRIPTION DRUG |
| FDA Application Number: | ANDA040772 |
| Marketing Category: | ANDA |
| Start Marketing Date: | 20080910 |
| Package NDC: | 66758-044-03 |
| Package Description: | 10 VIAL, SINGLE-USE in 1 CARTON (66758-044-03) > 10 mL in 1 VIAL, SINGLE-USE (66758-044-01) |
| NDC Code | 66758-044-03 |
| Proprietary Name | Fluorouracil |
| Package Description | 10 VIAL, SINGLE-USE in 1 CARTON (66758-044-03) > 10 mL in 1 VIAL, SINGLE-USE (66758-044-01) |
| Product NDC | 66758-044 |
| Product Type Name | HUMAN PRESCRIPTION DRUG |
| Non Proprietary Name | Fluorouracil |
| Dosage Form Name | INJECTION, SOLUTION |
| Route Name | INTRAVENOUS |
| Start Marketing Date | 20080910 |
| Marketing Category Name | ANDA |
| Labeler Name | Sandoz Inc |
| Substance Name | FLUOROURACIL |
| Strength Number | 50 |
| Strength Unit | mg/mL |
| Pharmaceutical Classes | Nucleic Acid Synthesis Inhibitors [MoA],Nucleoside Metabolic Inhibitor [EPC] |